NorthWest Biotherapeutics Inc (NWBO)

[antihama]

Pqr, true that Sotorasib is not a biologic but TLD is TLD (they are both apples) and once you have it the clock starts ticking. The Criteria for BTD is - a drug that treats a Serious condition, AND Preliminary clinical evidence that indicates that the drug may demonstrate substantial improvement over available therapy on one or more clinically significant endpoints. Besides seeing this evidence on May 10th, you know they have every nook and cranny of the data analyzed. I mean they had since Nov 2020 to figure that out. And presumably the journal article will have all that too. Is it too much to expect NWBO to come through w this expectation? Maybe but hope not.